litlas
Log inCreate account

Marc Buyse

Active 1983–2025

155
Papers
42,083
Citations
98
h-index
152
i10-index

Citations

Citations per year for Marc Buyse1984: 2 citations1985: 4 citations1986: 2 citations1987: 8 citations1988: 12 citations1989: 16 citations1990: 33 citations1991: 24 citations1992: 29 citations1993: 41 citations1994: 37 citations1995: 50 citations1996: 42 citations1997: 61 citations1998: 73 citations1999: 89 citations2000: 107 citations2001: 96 citations2002: 151 citations2003: 97 citations2004: 136 citations2005: 167 citations2006: 177 citations2007: 253 citations2008: 359 citations2009: 408 citations2010: 468 citations2011: 438 citations2012: 415 citations2013: 394 citations2014: 407 citations2015: 372 citations2016: 325 citations2017: 339 citations2018: 259 citations2019: 913 citations2020: 861 citations2021: 824 citations2022: 642 citations2023: 435 citations2024: 682 citations2025: 311 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,642 citing papers, 23.7% of this breakdownUnited Kingdom: 1,280 citing papers, 8.3% of this breakdownChina: 969 citing papers, 6.3% of this breakdownItaly: 946 citing papers, 6.1% of this breakdownGermany: 834 citing papers, 5.4% of this breakdownFrance: 808 citing papers, 5.3% of this breakdownCanada: 641 citing papers, 4.2% of this breakdownBelgium: 573 citing papers, 3.7% of this breakdownNetherlands: 533 citing papers, 3.5% of this breakdownJapan: 486 citing papers, 3.2% of this breakdownSpain: 479 citing papers, 3.1% of this breakdownAustralia: 458 citing papers, 3% of this breakdown
0%23.7%Other 24.2%

Institutions

Fields

  • Medicine63.4%
  • Biochemistry, Genetics and Molecular Biology25.9%
  • Mathematics1.8%
  • Immunology and Microbiology1.8%
  • Computer Science1.6%
  • Economics, Econometrics and Finance1%
  • Other4.5%

Topics

  • Breast Cancer Treatment Studies4.7%
  • HER2/EGFR in Cancer Research4.7%
  • Colorectal Cancer Treatments and Studies4.3%
  • Colorectal Cancer Surgical Treatments3%
  • Cancer Treatment and Pharmacology2.6%
  • Cancer Genomics and Diagnostics2.5%
  • Other78.2%

Coauthors

All papers

Open in search
  1. Adjuvant Trastuzumab in HER2-Positive Breast Cancer

    Authors: Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, Miguel Martín, Michael F. Press, John R. Mackey, John A. Glaspy, Arlene Chan, Marek Pawlicki, Tamás Pintér, Vicente Valero, Mei-Ching Liu, Guido Sauter, Gϋnter von Minckwitz, F. Visco, Valerie Bée, Marc Buyse, Belguendouz Bendahmane, Isabelle Tabah-Fisch, Mary-Ann Lindsay, A. Riva, John Crown - New England Journal of Medicine 2011 cited by 2,775

  2. Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

    Authors: Wanling Xie, Meredith M. Regan, Marc Buyse, Susan Halabi, Philip W. Kantoff, Oliver Sartor, Howard R. Soule, Noel W. Clarke, Laurence Collette, James J. Dignam, Karim Fizazi, Wendy R. Paruleker, Howard M. Sandler, Matthew R. Sydes, Bertrand Tombal, Scott Williams, Christopher J. Sweeney, on behalf of the ICECaP Working Group - Journal of Clinical Oncology 2017 cited by 434

  3. Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Authors: Daniel J. Sargent, Alberto Sobrero, Axel Grothey, Michael J. O’Connell, Marc Buyse, Thierry André, Yan Zheng, Erin Green, Roberto Labianca, Chris J. O’Callaghan, Jean François Seitz, Guido Francini, Daniel G. Haller, Greg Yothers, Richard M. Goldberg, Aimery de Gramont - Journal of Clinical Oncology 2009 cited by 676

  4. Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial

    Authors: J. Randolph Hecht, Yung‐Jue Bang, Shukui Qin, Hyun Cheol Chung, Jianming Xu, Joon Oh Park, Krzysztof Jeziorski, Yaroslav Shparyk, Paulo M. Hoff, Alberto Sobrero, Pamela Salman, Jin Li, Светлана Проценко, Zev A. Wainberg, Marc Buyse, Karen Afenjar, Vincent Houé, Agathe Garcia, Tomomi Kaneko, Yingjie Huang, S. Khan‐Wasti, Sergio Santillana, Michael F. Press, Dennis J. Slamon - Journal of Clinical Oncology 2015 cited by 621

  5. Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

    Authors: Christos Sotiriou, Pratyaksha Wirapati, Sherene Loi, Adrian L. Harris, Steve Fox, Johanna Smeds, Hans Nordgren, Pierre Farmer, Viviane Praz, Benjamin Haibe‐Kains, Christine Desmedt, Denis Larsimont, Fátima Cardoso, Hans Peterse, Dimitry S.A. Nuyten, Marc Buyse, Marc J. van de Vijver, Jonas Bergh, Martine Piccart, Mauro Delorenzi - JNCI Journal of the National Cancer Institute 2006 cited by 2,127

  6. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Miguel Martín, Frankie A. Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy, Hiroji Iwata, Gϋnter von Minckwitz, Stephen Chia, Janine Mansi, Carlos H. Barrios, Michael Gnant, Z. Tomasevic, Neelima Denduluri, Robert Šeparović, Erhan Gökmen, Anna Bashford, Manuel Ruíz Borrego, Sung‐Bae Kim, Erik Jakobsen, A. Ciceniene, Kenichi Inoue, Friedrich Overkamp, Joan B. Heijns, Anne Armstrong, John S. Link, Anil A. Joy, Richard Bryce, Alvin Wong, Susan Moran, Bin Yao, Feng Xu, Alan Auerbach, Marc Buyse, Arlene Chan, Vernon Harvey, Rudolf Tomek, Nicholas J. Robert, Ira Gore, John W. Smith, Norikazu Masuda, S. Di Sean Kendall, William Graydon Harker, Katarína Petráková, Ángel Guerrero‐Zotano, Amparo Ruiz Simón, Zora Neskovic Konstantinovic, Nicholas Iannotti, Pierfrancesco Tassone, Gladys Rodriguez, Noelia Jáñez Martínez, Carmen Crespo Massieu, Snezana Smickoska, Işıl Somali, Uğur Yılmaz, Mirta Garcia Alonso, Adolfo Rosales, Soeren Cold, Ann Knoop, Debra A. Patt, Beth A. Hellerstedt, Serafin Morales Murillo, Ingrid A. Mayer, Julie A. Means‐Powell, Rina Hui, Francis M. Senecal, Richard Hendry De Boer, Zhenzhou Shen, A.A. Luczak, Joanna W.Y. Chui, Janice Tsang, István Láng, Yoshiaki Rai, Yasuo Hozumi, Albert J. ten Tije, Manish Bhandari, Cynthia R. Osborne, Shoichiro Ohtani, Kenji Higaki, Kenichi Watanabe, Kazunori TAGUCHI, Masato Takahashi, Sladjana Filipovic, Vincent Hansen, Vijayarama Phooshkooru Rao, Manish Gupta, Petar Petrov, Bruno Coudert, Željko Vojnović, Zsofia Polya, Toshiko Miyaki, Naohito Yamamoto, Stephen Brincat, Krzysztof Leśniewski-Kmak, Ewa Chmielowska, Ruemu Birhiray, Marc L. Citron, Steven W. Papish, William L. Berry, Sven Tyge Langkjer, José Á. García-Sáenz and 526 more - The Lancet Oncology 2017 cited by 589

  7. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer

    Authors: Emmanouil Fokas, Ane Appelt, Rob Glynne‐Jones, Geerard L. Beets, Rodrigo Oliva Perez, Julio García‐Aguilar, Éric Rullier, J. Joshua Smith, Corrie A.M. Marijnen, Femke P. Peters, Maxine van der Valk, Regina G. H. Beets‐Tan, Arthur Sun Myint, Jean‐Pierre Gérard, Simon P. Bach, Michael Ghadimi, Ralf‐Dieter Hofheinz, Krzysztof Bujko, Cihan Gani, Karin Haustermans, Bruce D. Minsky, Ethan B. Ludmir, Nicholas P. West, Maria Antonietta Gambacorta, Vincenzo Valentini, Marc Buyse, Andrew G. Renehan, Alexandra Gilbert, David Sebag‐Montefiore, Claus Rödel - Nature Reviews Clinical Oncology 2021 cited by 244

  8. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

    Authors: Christophe Tournigand, Thierry André, Emmanuel Achille, Gérard Lledo, Michel Flesh, D. Méry-Mignard, Emmanuel Quinaux, C. Couteau, Marc Buyse, G. Ganem, Bruno Landi, Philippe Colin, Christophe Louvet, Aimery de Gramont - Journal of Clinical Oncology 2003 cited by 2,920

  9. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Arlene Chan, Suzette Delaloge, Frankie A. Holmes, Beverly Moy, Hiroji Iwata, Vernon Harvey, Nicholas J. Robert, Tajana Silovski, Erhan Gökmen, Gϋnter von Minckwitz, Bent Ejlertsen, Stephen Chia, Janine Mansi, Carlos H. Barrios, Michael Gnant, Marc Buyse, Ira Gore, John W. Smith, Graydon Harker, Norikazu Masuda, Katarína Petráková, Ángel Guerrero Zotano, Nicholas Iannotti, Gladys Rodriguez, Pierfrancesco Tassone, Alvin Wong, Richard Bryce, Yining Ye, Bin Yao, Miguel Martín - The Lancet Oncology 2016 cited by 565

  10. Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti–Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer

    Authors: Marion van Mackelenbergh, Sibylle Loibl, Michael Untch, Marc Buyse, Charles E. Geyer, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine Piccart, Hervé Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D. Gelber, Coralie Poncet, Pierre Squifflet, Everardo D. Saad, Dominik Heinzmann, Carsten Denkert, Priya Rastogi, Javier Cortés, Valentina Guarneri, Evandro de Azambuja, David Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar, on behalf of the CTNeoBC project - Journal of Clinical Oncology 2023 cited by 96

  11. The validation of surrogate endpoints in meta-analyses of randomized experiments

    Authors: Marc Buyse, Geert Molenberghs, Tomasz Burzykowski, Didier Renard, Helena Geys - Biostatistics 2000 cited by 605

  12. Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

    Authors: Christine Desmedt, Benjamin Haibe‐Kains, Pratyaksha Wirapati, Marc Buyse, Denis Larsimont, Gianluca Bontempi, Mauro Delorenzi, Martine Piccart, Christos Sotiriou - Clinical Cancer Research 2008 cited by 842

  13. A Phase III Open-Label Trial to Evaluate Efficacy and Safety of CPI-613 Plus Modified FOLFIRINOX (MFFX) versus FOLFIRINOX (FFX) in Patients with Metastatic Adenocarcinoma of the Pancreas

    Authors: Philip A. Philip, Marc Buyse, Angela Alistar, Caio M.S. Rocha Lima, Sanjeev Luther, Timothy S. Pardee, Eric Van Cutsem - Future Oncology 2019 cited by 99

  14. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases

    Authors: Ugo Pastorino, Marc Buyse, Godehard Friedel, Robert J. Ginsberg, Philippe Girard, Peter Goldstraw, Michael Johnston, Patricia McCormack, Harvey I. Pass, Joe B. Putnam - Journal of Thoracic and Cardiovascular Surgery 1997 cited by 1,535

  15. Endpoints in Adjuvant Treatment Trials: A Systematic Review of the Literature in Colon Cancer and Proposed Definitions for Future Trials

    Authors: Cornelis J. A. Punt, Marc Buyse, C.-H. Köhne, Peter Hohenberger, Roberto Labianca, Hans‐Joachim Schmoll, Lars Påhlman, Alberto Sobrero, Jean‐Yves Douillard - JNCI Journal of the National Cancer Institute 2007 cited by 378

  16. Common pitfalls in statistical analysis: The perils of multiple testing

    Authors: Priya Ranganathan, C.S. Pramesh, Marc Buyse - Perspectives in Clinical Research 2016 cited by 207

  17. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial

    Authors: Sara A. Hurvitz, Fabrice André, Zefei Jiang, Zhimin Shao, Max S. Mano, Silvia P. Neciosup, Ling-Min Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Lydia Dreosti, Howard A. Burris, Masakazu Toi, Marc Buyse, David Cabaribere, Mary-Ann Lindsay, Shantha Rao, Lida Pacaud, Tetiana Taran, Dennis J. Slamon - The Lancet Oncology 2015 cited by 306

  18. Outcome measures in multimodal rectal cancer trials

    Authors: Emmanouil Fokas, Rob Glynne‐Jones, Ane Appelt, Geerard L. Beets, Geerard L. Beets, Karin Haustermans, Corrie A.M. Marijnen, Bruce D. Minsky, Ethan B. Ludmir, Philip Quirke, David Sebag‐Montefiore, Julio García‐Aguilar, Maria Antonietta Gambacorta, Vincenzo Valentini, Marc Buyse, Claus Rödel - The Lancet Oncology 2020 cited by 104

  19. A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration

    Authors: Timothy L. Jackson, Jason S. Slakter, Marc Buyse, Marc Buyse, Pravin U. Dugel, Charles C. Wykoff, David S. Boyer, Michael Gerometta, Megan E. Baldwin, Clare F. Price, Clare F. Price, Bohdan Kousal, Jan Studnicka, Michal Veith, Catherine Creuzot-Garcher, Flore De Bats, David Gaucher, Martine Mauget-Faysse, Eric Souied, Ramin Tadayoni, Andrea Facsko, Agnes Kerénvi, Andras Papp, Alexis Tsorbatzoglou, Gabor Vogt, Yoreh Barak, Itay Chowers, Michaella Goldstein, Joel Hanhart, Haya Morori-Katz, Irit Rosenblatt, Alexander Rubowitz, Oren Tomkins Netzer, Francesco Bandello, Antonio Ciardella, Federico Ricci, Giovanni Staurenghi, Gianni Virgili, Kristine Baumane, Guna Laganovska, Signe Ozolina, Ilze Strautmane, Bartlomiej Kaluzny, Jerzy Mackiewicz, Marta Misiuk-Hoilo, Ewa Mrukwa-Kominek, Piotr Oleksy, Krystyna Raczynska, Tomasz Zarnowski, Alfredo Adan, Javier Araiz, Anna Boixadera, Alvaro Fernández-Vega, Alfredo Garcia Layana, Francisco Gomez-Ulla, Javier Montero, Jose Maria Ruiz Moreno, David Gilmour, Timothy Jackson, Timothy Jackson, Sidath Liyanage, Luke Membrey, Geeta Menon, Niro Narendran, Sobha Sivaprasad, Daniel Alfaro, Andrew Antoszyk, Carl Baker, Ivan Batille, Brian Berger, David Boyer, William Bridges, Harold Brooks, David Brown, Margaret Chang, Daniel Chao, Sanford Chen, Courtney Crawford, Pravin Dugel, Alexander Eaton, David Eichenbaum, Jordana Fein, Leonard Feiner, Christina Flaxel, Frank Garber, Alan Gordon, Sunil Gupta, Curtis Haegedorn, George Hampton, Thomas Hanscom, Vrinda Hershberger, Peter Kaiser, Randy Katz, Arshad Khanani, Erik Kruger, Denis Marcus, Matthew Ohr, Sunil Patel, Joel Pearlman, Richard Pesavento and 21 more - Ophthalmology 2023 cited by 50

  20. Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

    Authors: Mitch Dowsett, Jack Cuzick, J. N. Ingle, Alan S. Coates, John Forbes, Judith M. Bliss, Marc Buyse, Michael Baum, Aman U. Buzdar, Marco Colleoni, R. Charles Coombes, Claire Snowdon, Michael Gnant, R. Jakesz, Manfred Kaufmann, Francesco Boccardo, Jon Godwin, Christina Davies, Richárd Pető - Journal of Clinical Oncology 2009 cited by 815

  21. Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Authors: Daniel J. Sargent, Harry S. Wieand, Daniel G. Haller, Richard Gray, Jacqueline Benedetti, Marc Buyse, Roberto Labianca, Jean François Seitz, Christopher J. O’Callaghan, Guido Francini, Axel Grothey, Michael J. O’Connell, Paul J. Catalano, Charles D. Blanke, David Kerr, Erin Green, Norman Wolmark, Thierry André, Richard M. Goldberg, Aimery de Gramont - Journal of Clinical Oncology 2005 cited by 712

  22. Common pitfalls in statistical analysis: Clinical versus statistical significance

    Authors: Priya Ranganathan, C.S. Pramesh, Marc Buyse - Perspectives in Clinical Research 2015 cited by 264

  23. Surrogate threshold effect: an alternative measure for meta‐analytic surrogate endpoint validation

    Authors: Tomasz Burzykowski, Marc Buyse - Pharmaceutical Statistics 2006 cited by 201

  24. Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

    Authors: Élisabeth Quoix, Rodryg Ramlau, Virginie Westeel, Zsolt Pápai, Anne Madroszyk, Alain Rivière, P. Koralewski, Jean-Luc Breton, Erich Stoelben, Denis Braun, D. Debieuvre, H. Léna, Marc Buyse, Marie‐Pierre Chenard, Bruce Acres, G Lacoste, Bérangère Bastien, Annette Tavernaro, Nadine Bizouarne, Jean‐Yves Bonnefoy, Jean‐Marc Limacher - The Lancet Oncology 2011 cited by 265